The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening ...

The U.S. Food and Drug Administration said on Tuesday it is starting a process to remove fluoride supplements for children ...

Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR ...

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Several ASX-listed companies have partnered with Cell Therapies, based at Peter Mac to manufacture CAR-T and other cell ...

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...

The approval in MIBC was based on positive results from the phase 3 NIAGARA trial, in which the Imfinzi regimen demonstrated ...

Brittany Lincicome calls it one of her favorite stops on the LPGA Tour, and her competitors agree. (May 13, 2025) ...